Skye Bioscience Inc (SKYE)
12.06
+0.10
(+0.84%)
USD |
NASDAQ |
May 24, 16:00
12.00
-0.06
(-0.50%)
After-Hours: 20:00
Skye Bioscience Cash from Operations (Quarterly): -4.708M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.708M |
| December 31, 2023 | -3.845M |
| September 30, 2023 | -4.055M |
| June 30, 2023 | -1.992M |
| March 31, 2023 | -4.061M |
| December 31, 2022 | -4.872M |
| September 30, 2022 | -2.057M |
| June 30, 2022 | -2.901M |
| March 31, 2022 | -2.915M |
| December 31, 2021 | -1.969M |
| September 30, 2021 | -1.486M |
| June 30, 2021 | -1.671M |
| March 31, 2021 | -1.348M |
| December 31, 2020 | -1.786M |
| September 30, 2020 | -1.974M |
| June 30, 2020 | -1.028M |
| March 31, 2020 | -1.266M |
| December 31, 2019 | -1.503M |
| September 30, 2019 | -1.488M |
| June 30, 2019 | -1.605M |
| March 31, 2019 | -1.431M |
| December 31, 2018 | -1.014M |
| Date | Value |
|---|---|
| September 30, 2018 | -0.8163M |
| June 30, 2018 | -1.059M |
| March 31, 2018 | -1.053M |
| December 31, 2017 | -2.144M |
| September 30, 2017 | -0.10M |
| June 30, 2017 | -0.2714M |
| March 31, 2017 | -0.8164M |
| December 31, 2016 | -0.6628M |
| September 30, 2016 | -0.5117M |
| June 30, 2016 | -1.23M |
| March 31, 2016 | -1.148M |
| December 31, 2015 | -1.114M |
| September 30, 2015 | -1.295M |
| June 30, 2015 | -0.5677M |
| March 31, 2015 | -0.7517M |
| July 31, 2014 | 0.0079M |
| April 30, 2014 | 0.0033M |
| January 31, 2014 | -0.0041M |
| October 31, 2013 | -0.0088M |
| July 31, 2013 | 0.0082M |
| April 30, 2013 | -0.0015M |
| January 31, 2013 | -0.0125M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.872M
Minimum
Dec 2022
-1.028M
Maximum
Jun 2020
-2.426M
Average
-1.972M
Median
Cash from Operations (Quarterly) Benchmarks
| Cutera Inc | -37.63M |
| Medical Marijuana Inc | -- |
| OrthoPediatrics Corp | -6.69M |
| RAPT Therapeutics Inc | -27.08M |
| NovaBay Pharmaceuticals Inc | -1.572M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 1.142M |
| Cash from Financing (Quarterly) | 85.65M |
| Free Cash Flow | -14.61M |
| Free Cash Flow Per Share (Quarterly) | -0.1683 |
| Free Cash Flow Yield | -9.30% |